Donor Characteristics | Overall (n = 32) | BW ≤ 5 kg (n = 7) | 5 < BW ≤ 10 kg (n = 25) |
---|---|---|---|
Age, month (Range)* | 8.9 (0.3–41.3) | 1.3 (0.3–5.6) | 12.0 (1.7–41.3) |
Sex, male/female (%) | 15 (46.9%)/17 (53.1%) | 2 (28.6%)/5 (71.4%) | 13 (52.0%)/12 (48.0%) |
Body weight, kg (Range)* | 7.8 (3.0–10.0) | 3.9 (3.0–5.0) | 9.0 (5.2–10.0) |
Causes of death, number (%) | |||
Brain injury | 7 (21.9%) | 0 | 7 (28.0%) |
Pneumonia or respiratory failure | 6 (18.8%) | 3 (42.9%) | 3 (12.0%) |
Cerebral hemorrhage or hernia | 5 (15.6%) | 1 (14.3%) | 4 (16.0%) |
Intracranial infection | 3 (9.4%) | 1 (14.3%) | 2 (8.0%) |
Brain tumor | 2 (6.3%) | 0 | 2 (8.0%) |
Trauma | 2 (6.3%) | 0 | 2 (8.0%) |
Congenital heart disease | 1 (3.1%) | 1 (14.3%) | 0 |
Unknown | 6 (18.8%) | 1 (14.3%) | 5 (20.0%) |
Warm ischemia time, min (Range) | 5.0 (0.0–12.0) | 5.0 (0.0–5.0) | 5.0 (0.0–12.0) |
Cold ischemia time, hour (Range) | 8.0 (2.0–23.5) | 10.0 (6.0–22.0) | 7.0 (2.0–23.5) |
Recipient characteristics | Overall (n = 56) | BW ≤ 5 kg (n = 13) | 5 < BW ≤ 10 kg (n = 43) |
Age, year | 9.0 (1.4–17.0) | 7.0 (5.0–12.0) | 9.0 (1.4–17.0) |
Sex, male/female (%) | 32 (57.1%)/24 (42.9%) | 9 (69.2%)/4 (30.8%) | 25 (58.1%)/18 (41.9%) |
Body weight, kg (Range) | 22.0 (6.5–44.0) | 23.0 (13.0–29.0) | 22.0 (6.5–44.0) |
Donor/Recipient BW Ratio, (Range)* | 1:3.2 (1:0.7–1:9.1) | 1:5.6 (1:2.6–1:9.1) | 1:2.6 (1:0.7–1:6.25) |
Waiting time since dialysis, month (Range) | 8.0 (0.0–72.0) | 7.0 (0.0–36.0) | 8.0 (0.0–72.0) |
Type of dialysis, number (%) | |||
Preemptive | 6 (10.7%) | 1 (7.7%) | 5 (11.6%) |
PD | 20 (35.7%) | 3 (23.1%) | 17 (39.5%) |
HD | 25 (44.7%) | 7 (53.8%) | 18 (41.9%) |
PD + HD | 5 (8.9%) | 2 (15.4%) | 3 (7.0%) |
HLA mismatch number (Range) | 3 (2–6) | 3 (3–6) | 3 (2–6) |
Primary disease, number (%) | |||
Glomerulonephritis | 35 (62.5%) | 10 (76.9%) | 25 (58.1%) |
FSGS | 5 (8.9%) | 1 (7.7%) | 4 (9.3%) |
IgA nephropathy | 3 (5.3%) | 0 | 3 (7.0%) |
Congenital renal dysplasia | 2 (3.6%) | 1 (7.7%) | 1 (2.3%) |
Other | 11 (19.7%) | 1 (7.7%) | 10 (23.3%) |
Follow-up time, month (Range) | 23.0 (0.03–53.0) | 26.0 (0.03–34.6) | 21.5 (0.3–53.0) |